[1] Lass-Florl C, Mayr A. Human protothecosis[J]. Clin Microbiol Rev, 2007, 20(2): 230-242. [2] 章强强. 无绿藻的表型及其分子生物学鉴定[J]. 中国真菌学杂志, 2010, 5(1): 9-12. [3] 章强强. 无绿藻病的现状与发病原因分析[J]. 中国真菌学杂志, 2008, 3(5): 260-264. [4] Zhang QQ, Weng XH, LiL, et al. An unusual case of granulomatous lymphadenitis due to P.zopfii var. portoricensis in an immunocompetent man in China[J]. Int J Infect Dis, 14(Suppl 3), 2010, e32-e35. [5] Zhang QQ, Li L, Zhu LP, et al. Cutaneous Protothecosis in Patient with Diabetes Mellitus and Review of Published Case Reports[J]. Mycopathologia, 2012, 173(2-3): 163-171. [6] 章强强, 翁心华, 朱利平,等. 小型无绿藻性脑膜炎及其真菌学研究[J].中华皮肤科杂志, 2006, 39(8): 445-447. [7] Zhang QQ, Zhu LP, Weng XH, et al. Meningitis due to Prototheca wickerhamii: rare case in China[J]. Medical Mycology, 2007, 45(1):85-88. [8] 康俞莉, 章强强. 无绿藻的研究进展:从基础到临床[J]. 中国真菌学杂志, 2012,7 (4): 242 -246. [9] Maddur MS, Miossec P, Kaveri SV, et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies[J]. Am J Pathol, 2012, 181(1): 8-18. [10] Wilke CM, Bishop K, Fox D, et al. Deciphering the role of Th17 cells in human disease[J]. Trends Immunol, 2011, 32(12): 603-611. [11] Lin JS, Yang CW, Wang DW, et al. Dendritic cells cross-present exogenous fungal antigens to stimulate a protective CD8 T cell response in infection by Histoplasma capsulatum[J]. J Immunol, 2005, 174(10): 6282-6291. [12] Loures FV, Pina A, Felonato M, et al. Toll-like receptor 4 signaling leads to severe fungal infection associated with enhanced proinflammatory immunity and impaired expansion of regulatory T cells[J]. Infect Immun, 2010, 78(3): 1078-1088. [13] Robinson MJ, Osorio F, Rosas M, et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection[J]. J Exp Med, 2009, 206(9): 2037-2051. [14] Zelante T, De Luca A, D'Angelo C, et al. IL-17/Th17 in anti-fungal immunity: what's new[J]. Eur J Immunol, 2009, 39(3): 645-648. [15] Conti HR, Gaffen SL. Host responses to Candida albicans: Th17 cells and mucosal candidiasis[J]. Microbes Infect, 2010, 12(7): 518-527. [16] Deepe GS Jr, Gibbons RS. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum[J]. J Infect Dis, 2009, 200(1): 142-151. [17] Conti HR, Shen F, Nayyar N, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis[J]. J Exp Med, 2009, 206(2): 299-311. [18] Kagami S, Rizzo HL, Kurtz SE, et al. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans[J]. J Immunol, 2010, 185(9): 5453-5462. [19] Huang W, Na L, Fidel PL, et al. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice[J]. J Infect Dis, 2004, 190(3): 624-631. [20] Zelante T, Bozza S, De Luca A, et al. Th17 cells in the setting of Aspergillus infection and pathology[J]. Med Mycol, 2009, 47( Suppl 1): S162-169. [21] Eyerich K, Foerster S, Rombold S, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22[J]. J Invest Dermatol, 2008, 128(11): 2640-2645. |